Literature DB >> 33764426

Bi-allelic variants in HOPS complex subunit VPS41 cause cerebellar ataxia and abnormal membrane trafficking.

Leslie E Sanderson1, Kristina Lanko1, Maysoon Alsagob2,3, Rawan Almass2,4, Nada Al-Ahmadi2,5, Maryam Najafi6,7, Mohammad A Al-Muhaizea8, Hamad Alzaidan4, Hesham AlDhalaan8, Elena Perenthaler1, Herma C van der Linde1, Anita Nikoncuk1, Nikolas A Kühn1, Dinu Antony7, Tarek Mustafa Owaidah9, Salmo Raskin10, Luana Gabriela Dalla Rosa Vieira11, Romulo Mombach12, Najmeh Ahangari13, Tainá Regina Damaceno Silveira14, Najim Ameziane14, Arndt Rolfs14,15, Aljohara Alharbi9, Raghda M Sabbagh9, Khalid AlAhmadi8, Bashayer Alawam4, Hazem Ghebeh16, Aljouhra AlHargan2, Anoud A Albader2, Faisal S Binhumaid2, Ewa Goljan2, Dorota Monies2, Osama M Mustafa2, Mazhor Aldosary2, Albandary AlBakheet2, Banan Alyounes2, Faten Almutairi2, Ali Al-Odaib2, Durdane Bekar Aksoy17, A Nazli Basak18, Robin Palvadeau18, Daniah Trabzuni19, Jill A Rosenfeld20, Ehsan Ghayoor Karimiani21,22, Brian F Meyer2,23,24, Bedri Karakas25, Futwan Al-Mohanna26, Stefan T Arold27,28, Dilek Colak29, Reza Maroofian30, Henry Houlden30, Aida M Bertoli-Avella14, Miriam Schmidts6,7, Tahsin Stefan Barakat1, Tjakko J van Ham1, Namik Kaya2,24.   

Abstract

Membrane trafficking is a complex, essential process in eukaryotic cells responsible for protein transport and processing. Deficiencies in vacuolar protein sorting (VPS) proteins, key regulators of trafficking, cause abnormal intracellular segregation of macromolecules and organelles and are linked to human disease. VPS proteins function as part of complexes such as the homotypic fusion and vacuole protein sorting (HOPS) tethering complex, composed of VPS11, VPS16, VPS18, VPS33A, VPS39 and VPS41. The HOPS-specific subunit VPS41 has been reported to promote viability of dopaminergic neurons in Parkinson's disease but to date has not been linked to human disease. Here, we describe five unrelated families with nine affected individuals, all carrying homozygous variants in VPS41 that we show impact protein function. All affected individuals presented with a progressive neurodevelopmental disorder consisting of cognitive impairment, cerebellar atrophy/hypoplasia, motor dysfunction with ataxia and dystonia, and nystagmus. Zebrafish disease modelling supports the involvement of VPS41 dysfunction in the disorder, indicating lysosomal dysregulation throughout the brain and providing support for cerebellar and microglial abnormalities when vps41 was mutated. This provides the first example of human disease linked to the HOPS-specific subunit VPS41 and suggests the importance of HOPS complex activity for cerebellar function.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  zzm321990 VPS41zzm321990 ; cerebellar ataxia; membrane trafficking; neurodevelopmental disorder; zebrafish disease modelling

Year:  2021        PMID: 33764426     DOI: 10.1093/brain/awaa459

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  8 in total

Review 1.  The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes.

Authors:  Alessio Di Fonzo; Alberto Albanese; Hyder A Jinnah
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

Review 2.  Zebrafish Syndromic Albinism Models as Tools for Understanding and Treating Pigment Cell Disease in Humans.

Authors:  Sam J Neuffer; Cynthia D Cooper
Journal:  Cancers (Basel)       Date:  2022-03-30       Impact factor: 6.639

3.  PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy.

Authors:  Hormos Salimi Dafsari; Joshua G Pemberton; Elizabeth A Ferrer; Tony Yammine; Chantal Farra; Mohammad Hasan Mohammadi; Ehsan Ghayoor Karimiani; Narges Hashemi; Mirna Souaid; Sandra Sabbagh; Paria Najarzadeh Torbati; Suliman Khan; Emmanuel Roze; Andres Moreno-De-Luca; Aida M Bertoli-Avella; Henry Houlden; Tamas Balla; Reza Maroofian
Journal:  Ann Clin Transl Neurol       Date:  2022-07-25       Impact factor: 5.430

4.  A Novel Homozygous Founder Variant of RTN4IP1 in Two Consanguineous Saudi Families.

Authors:  Mazhor Aldosary; Maysoon Alsagob; Hanan AlQudairy; Ana C González-Álvarez; Stefan T Arold; Mohammad Anas Dababo; Omar A Alharbi; Rawan Almass; AlBandary AlBakheet; Dalia AlSarar; Alya Qari; Mysoon M Al-Ansari; Monika Oláhová; Saif A Al-Shahrani; Moeenaldeen AlSayed; Dilek Colak; Robert W Taylor; Mohammed AlOwain; Namik Kaya
Journal:  Cells       Date:  2022-10-07       Impact factor: 7.666

Review 5.  The multicellular interplay of microglia in health and disease: lessons from leukodystrophy.

Authors:  Woutje M Berdowski; Leslie E Sanderson; Tjakko J van Ham
Journal:  Dis Model Mech       Date:  2021-07-20       Impact factor: 5.758

Review 6.  Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.

Authors:  Xiaobo Wang; Jin-Bao Zhang; Kai-Jie He; Fen Wang; Chun-Feng Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

7.  A Novel GEMIN4 Variant in a Consanguineous Family Leads to Neurodevelopmental Impairment with Severe Microcephaly, Spastic Quadriplegia, Epilepsy, and Cataracts.

Authors:  Hesham Aldhalaan; Albandary AlBakheet; Sarah AlRuways; Nouf AlMutairi; Maha AlNakiyah; Reema AlGhofaili; Kelly J Cardona-Londoño; Khalid Omar Alahmadi; Hanan AlQudairy; Maha M AlRasheed; Dilek Colak; Stefan T Arold; Namik Kaya
Journal:  Genes (Basel)       Date:  2021-12-30       Impact factor: 4.096

8.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.

Authors:  Eva Medico Salsench; Reza Maroofian; Ruizhi Deng; Kristina Lanko; Anita Nikoncuk; Belén Pérez; Obdulia Sánchez-Lijarcio; Salvador Ibáñez-Mico; Antonina Wojcik; Marcelo Vargas; Nouriya Abbas Al-Sannaa; Marian Y Girgis; Tainá Regina Damaceno Silveira; Peter Bauer; Audrey Schroeder; Chin-To Fong; Amber Begtrup; Meisam Babaei; Mehran Beiraghi Toosi; Farah Ashrafzadeh; Shima Imannezhad; Mohammad Doosti; Najmeh Ahangari; Paria Najarzadeh Torbati; Ehsan Ghayoor Karimiani; David Murphy; Elisa Cali; Ibrahim H Kaya; Mohammad AlMuhaizea; Dilek Colak; Kelly J Cardona-Londoño; Stefan T Arold; Henry Houlden; Aida Bertoli-Avella; Namik Kaya; Tahsin Stefan Barakat
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.